Topic Review
Acorus tatarinowii Schott
Acorus tatarinowii Schott (A. tatarinowii) is a natural medicinal plant. It plays an indispensable role in the treatment of diseases by the empirical medicine system and has achieved remarkable curative effects.
  • 270
  • 12 Jun 2023
Topic Review
Escherichia coli-Based Therapeutic Protein Expression
Therapeutic proteins treat many acute and chronic diseases that were, until recently, considered untreatable. However, their high development cost keeps them out of reach of most patients around the world. One possible way to make manufacturing cheaper is to use newer technologies, such as Escherichia coli to make larger molecules, like full-length antibodies, that are normally only made in Chinese Hamster Ovary (CHO) cells, switch to continuous manufacturing, and change the process to cell-free synthesis. The advantages of using E. coli include a shorter production cycle, little risk of viral contamination, cell host stability, and a highly reproducible post-translational modification.
  • 75
  • 08 Dec 2023
Topic Review
Ganoderma Triterpenoids and Their Bioactivities
Ganoderma has been used as a traditional medicine in Asian countries to prevent and treat various diseases. Numerous publications are stating that Ganoderma species have a variety of beneficial medicinal properties, and investigations on different metabolic regulations of Ganoderma species, extracts or isolated compounds have been performed both in vitro and in vivo.
  • 594
  • 11 Jan 2023
Topic Review
2-Hydroxybutyric Acid for Insulin Resistance
Diabetes mellitus type 2 (T2D), commonly known as non-insulin-dependent diabetes mellitus (NIDDM) is responsible for up to 95% of diabetic cases worldwide. It is defined as a chronic condition characterized by the loss and/or dysfunction of β-cells and insulin resistance (IR) in effector tissues, which is immediately recognized by an increase in glucose levels in the bloodstream, i.e., hyperglycemia.
  • 666
  • 15 Dec 2021
Topic Review
3D Printing in Complex Medical Procedures
Medicine is a rapidly-evolving discipline, with progress picking up pace with each passing decade. This constant evolution results in the introduction of new tools and methods, which in turn occasionally leads to paradigm shifts across the affected medical fields. The following review attempts to showcase how 3D printing has begun to reshape and improve processes across various medical specialties and where it has the potential to make a significant impact. 
  • 351
  • 18 Mar 2022
Topic Review
3D-Bioprinting for Chronic Wound
Skin substitutes can provide a temporary or permanent treatment option for chronic wounds. The selection of skin substitutes depends on several factors, including the type of wound and its severity. Full-thickness skin grafts (SGs) require a well-vascularised bed and sometimes will lead to contraction and scarring formation. Besides, donor sites for full-thickness skin grafts are very limited if the wound area is big, and it has been proven to have the lowest survival rate compared to thick- and thin-split thickness. Tissue engineering technology has introduced new advanced strategies since the last decades to fabricate the composite scaffold via the 3D-bioprinting approach as a tissue replacement strategy. Considering the current global donor shortage for autologous split-thickness skin graft (ASSG), skin 3D-bioprinting has emerged as a potential alternative to replace the ASSG treatment. The three-dimensional (3D)-bioprinting technique yields scaffold fabrication with the combination of biomaterials and cells to form bioinks. 
  • 1.3K
  • 08 Jan 2022
Topic Review
A New Role of Acute Phase Proteins
The prevailing general view of acute-phase proteins (APPs) is that they are produced by the liver in response to the stress of the body as part of a systemic acute-phase response. A coordinated, local production of these proteins upon cell stress by the stressed cells has been demonstrated. The local, stress-induced APP production has been demonstrated in different tissues (kidney, breast cancer) and with different stressors (hypoxia, fibrosis and electromagnetic heat). Thus, this local acute-phase response (APR) seems to be a universal mechanism. APP production is an ancient defense mechanism observed in nematodes and fruit flies as well. Local APP production at the tissue level is also supported by sporadic literature data for single proteins.
  • 279
  • 01 Apr 2022
Topic Review
ABC Transporters in the Innate Immune System
The ATP-binding cassette transporters (ABC transporters) are a large family of proteins that transport a variety of substrates across cell plasma membranes. Because of this, they are involved in many physiological processes. It is of interest to note that many ABC transporters are involved in the transport of various lipids. In addition, this function may be related to the innate immune system. 
  • 671
  • 22 Dec 2022
Topic Review
Abdominal Aortic Aneurysms
This entry outlines recent preclinical and clinical advances in molecular imaging of abdominal aortic aneurysms (AAA) with a focus on molecular magnetic resonance imaging (MRI) of the extracellular matrix (ECM). In addition, developments in pharmacologic treatment of AAA targeting the ECM are reviewed and results from animal studies are contrasted with clinical trials. Abdominal aortic aneurysm (AAA) is an often fatal disease without non-invasive pharmacologic treatment options. The ECM, with collagen type I and elastin as major components, is the key structural component of the aortic wall and is recognized as a target tissue for both initiation and the progression of AAA. Molecular imaging allows in vivo measurement and characterization of biological processes at the cellular and molecular level and sets forth to visualize molecular abnormalities at an early stage of disease, facilitating novel diagnostic and therapeutic pathways. By providing surrogate criteria for the in vivo evaluation of the effects of pharmacological therapies, molecular imaging techniques targeting the ECM may facilitate the development of pharmacological drugs. In addition, molecular targets can also be used within theranostic approaches that have the potential for timely diagnosis and simultaneous medical therapy. Recent successes in preclinical studies suggest future opportunities for clinical translation. However, further clinical studies are needed to validate the most promising molecular targets for human application.
  • 459
  • 22 Sep 2021
Topic Review
Aberrant Circadian Rhythm in Huntington’s Disease
Huntington’s disease (HD) is a progressive neurodegenerative disorder characterized by abnormal progressive involuntary movements, cognitive deficits, sleep disturbances, and psychiatric symptoms. Notably, gamma-aminobutyric acid (GABA)-ergic neurons that express the vasoactive intestinal peptide (VIP) in the brain play a key role in the regulation of circadian rhythm and neuroplasticity. While an abnormal clock gene pathway has been associated with the inactivation of GABAergic VIP neurons, recent studies suggest the activation of this neuronal population in the brain positively contributes to neuroplasticity.
  • 428
  • 22 Dec 2022
  • Page
  • of
  • 68